1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Urine 1.2.3 Blood 1.2.4 Serum 1.3 Market by Application 1.3.1 Global Prostate Cancer Biomarker Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Cancer Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Biomarker Market Perspective (2016-2027) 2.2 Prostate Cancer Biomarker Growth Trends by Regions 2.2.1 Prostate Cancer Biomarker Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Prostate Cancer Biomarker Historic Market Share by Regions (2016-2021) 2.2.3 Prostate Cancer Biomarker Forecasted Market Size by Regions (2022-2027) 2.3 Prostate Cancer Biomarker Industry Dynamic 2.3.1 Prostate Cancer Biomarker Market Trends 2.3.2 Prostate Cancer Biomarker Market Drivers 2.3.3 Prostate Cancer Biomarker Market Challenges 2.3.4 Prostate Cancer Biomarker Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Biomarker Players by Revenue 3.1.1 Global Top Prostate Cancer Biomarker Players by Revenue (2016-2021) 3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Players (2016-2021) 3.2 Global Prostate Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Biomarker Revenue 3.4 Global Prostate Cancer Biomarker Market Concentration Ratio 3.4.1 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Biomarker Revenue in 2020 3.5 Prostate Cancer Biomarker Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Biomarker Product Solution and Service 3.7 Date of Enter into Prostate Cancer Biomarker Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Biomarker Breakdown Data by Type 4.1 Global Prostate Cancer Biomarker Historic Market Size by Type (2016-2021) 4.2 Global Prostate Cancer Biomarker Forecasted Market Size by Type (2022-2027) 5 Prostate Cancer Biomarker Breakdown Data by Application 5.1 Global Prostate Cancer Biomarker Historic Market Size by Application (2016-2021) 5.2 Global Prostate Cancer Biomarker Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Prostate Cancer Biomarker Market Size (2016-2027) 6.2 North America Prostate Cancer Biomarker Market Size by Type 6.2.1 North America Prostate Cancer Biomarker Market Size by Type (2016-2021) 6.2.2 North America Prostate Cancer Biomarker Market Size by Type (2022-2027) 6.2.3 North America Prostate Cancer Biomarker Market Size by Type (2016-2027) 6.3 North America Prostate Cancer Biomarker Market Size by Application 6.3.1 North America Prostate Cancer Biomarker Market Size by Application (2016-2021) 6.3.2 North America Prostate Cancer Biomarker Market Size by Application (2022-2027) 6.3.3 North America Prostate Cancer Biomarker Market Size by Application (2016-2027) 6.4 North America Prostate Cancer Biomarker Market Size by Country 6.4.1 North America Prostate Cancer Biomarker Market Size by Country (2016-2021) 6.4.2 North America Prostate Cancer Biomarker Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Prostate Cancer Biomarker Market Size (2016-2027) 7.2 Europe Prostate Cancer Biomarker Market Size by Type 7.2.1 Europe Prostate Cancer Biomarker Market Size by Type (2016-2021) 7.2.2 Europe Prostate Cancer Biomarker Market Size by Type (2022-2027) 7.2.3 Europe Prostate Cancer Biomarker Market Size by Type (2016-2027) 7.3 Europe Prostate Cancer Biomarker Market Size by Application 7.3.1 Europe Prostate Cancer Biomarker Market Size by Application (2016-2021) 7.3.2 Europe Prostate Cancer Biomarker Market Size by Application (2022-2027) 7.3.3 Europe Prostate Cancer Biomarker Market Size by Application (2016-2027) 7.4 Europe Prostate Cancer Biomarker Market Size by Country 7.4.1 Europe Prostate Cancer Biomarker Market Size by Country (2016-2021) 7.4.2 Europe Prostate Cancer Biomarker Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Biomarker Market Size (2016-2027) 8.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Type 8.2.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2027) 8.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Application 8.3.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2027) 8.4 Asia-Pacific Prostate Cancer Biomarker Market Size by Region 8.4.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prostate Cancer Biomarker Market Size (2016-2027) 9.2 Latin America Prostate Cancer Biomarker Market Size by Type 9.2.1 Latin America Prostate Cancer Biomarker Market Size by Type (2016-2021) 9.2.2 Latin America Prostate Cancer Biomarker Market Size by Type (2022-2027) 9.2.3 Latin America Prostate Cancer Biomarker Market Size by Type (2016-2027) 9.3 Latin America Prostate Cancer Biomarker Market Size by Application 9.3.1 Latin America Prostate Cancer Biomarker Market Size by Application (2016-2021) 9.3.2 Latin America Prostate Cancer Biomarker Market Size by Application (2022-2027) 9.3.3 Latin America Prostate Cancer Biomarker Market Size by Application (2016-2027) 9.4 Latin America Prostate Cancer Biomarker Market Size by Country 9.4.1 Latin America Prostate Cancer Biomarker Market Size by Country (2016-2021) 9.4.2 Latin America Prostate Cancer Biomarker Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Biomarker Market Size (2016-2027) 10.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Type 10.2.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2027) 10.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Application 10.3.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2027) 10.4 Middle East & Africa Prostate Cancer Biomarker Market Size by Country 10.4.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Introduction 11.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.1.5 Thermo Fisher Scientific Recent Development 11.2 QIAGEN 11.2.1 QIAGEN Company Details 11.2.2 QIAGEN Business Overview 11.2.3 QIAGEN Prostate Cancer Biomarker Introduction 11.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.2.5 QIAGEN Recent Development 11.3 Roche Diagnostics 11.3.1 Roche Diagnostics Company Details 11.3.2 Roche Diagnostics Business Overview 11.3.3 Roche Diagnostics Prostate Cancer Biomarker Introduction 11.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.3.5 Roche Diagnostics Recent Development 11.4 Beckman Coulter 11.4.1 Beckman Coulter Company Details 11.4.2 Beckman Coulter Business Overview 11.4.3 Beckman Coulter Prostate Cancer Biomarker Introduction 11.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.4.5 Beckman Coulter Recent Development 11.5 Myriad Genetics 11.5.1 Myriad Genetics Company Details 11.5.2 Myriad Genetics Business Overview 11.5.3 Myriad Genetics Prostate Cancer Biomarker Introduction 11.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.5.5 Myriad Genetics Recent Development 11.6 Sanofi-Aventis 11.6.1 Sanofi-Aventis Company Details 11.6.2 Sanofi-Aventis Business Overview 11.6.3 Sanofi-Aventis Prostate Cancer Biomarker Introduction 11.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.6.5 Sanofi-Aventis Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Prostate Cancer Biomarker Introduction 11.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.7.5 Pfizer Recent Development 11.8 MDx Health 11.8.1 MDx Health Company Details 11.8.2 MDx Health Business Overview 11.8.3 MDx Health Prostate Cancer Biomarker Introduction 11.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2016-2021) 11.8.5 MDx Health Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Prostate Cancer Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Urine Table 3. Key Players of Blood Table 4. Key Players of Serum Table 5. Global Prostate Cancer Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Prostate Cancer Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Prostate Cancer Biomarker Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Prostate Cancer Biomarker Market Share by Regions (2016-2021) Table 9. Global Prostate Cancer Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Prostate Cancer Biomarker Market Share by Regions (2022-2027) Table 11. Prostate Cancer Biomarker Market Trends Table 12. Prostate Cancer Biomarker Market Drivers Table 13. Prostate Cancer Biomarker Market Challenges Table 14. Prostate Cancer Biomarker Market Restraints Table 15. Global Prostate Cancer Biomarker Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Prostate Cancer Biomarker Market Share by Players (2016-2021) Table 17. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2020) Table 18. Ranking of Global Top Prostate Cancer Biomarker Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Prostate Cancer Biomarker Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Prostate Cancer Biomarker Product Solution and Service Table 22. Date of Enter into Prostate Cancer Biomarker Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 25. Global Prostate Cancer Biomarker Revenue Market Share by Type (2016-2021) Table 26. Global Prostate Cancer Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Prostate Cancer Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Prostate Cancer Biomarker Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Prostate Cancer Biomarker Revenue Market Share by Application (2016-2021) Table 30. Global Prostate Cancer Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Prostate Cancer Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 33. North America Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million) Table 35. North America Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million) Table 62. Thermo Fisher Scientific Company Details Table 63. Thermo Fisher Scientific Business Overview Table 64. Thermo Fisher Scientific Prostate Cancer Biomarker Product Table 65. Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 66. Thermo Fisher Scientific Recent Development Table 67. QIAGEN Company Details Table 68. QIAGEN Business Overview Table 69. QIAGEN Prostate Cancer Biomarker Product Table 70. QIAGEN Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 71. QIAGEN Recent Development Table 72. Roche Diagnostics Company Details Table 73. Roche Diagnostics Business Overview Table 74. Roche Diagnostics Prostate Cancer Biomarker Product Table 75. Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 76. Roche Diagnostics Recent Development Table 77. Beckman Coulter Company Details Table 78. Beckman Coulter Business Overview Table 79. Beckman Coulter Prostate Cancer Biomarker Product Table 80. Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 81. Beckman Coulter Recent Development Table 82. Myriad Genetics Company Details Table 83. Myriad Genetics Business Overview Table 84. Myriad Genetics Prostate Cancer Biomarker Product Table 85. Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 86. Myriad Genetics Recent Development Table 87. Sanofi-Aventis Company Details Table 88. Sanofi-Aventis Business Overview Table 89. Sanofi-Aventis Prostate Cancer Biomarker Product Table 90. Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 91. Sanofi-Aventis Recent Development Table 92. Pfizer Company Details Table 93. Pfizer Business Overview Table 94. Pfizer Prostate Cancer Biomarker Product Table 95. Pfizer Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 96. Pfizer Recent Development Table 97. MDx Health Company Details Table 98. MDx Health Business Overview Table 99. MDx Health Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million) Table 100. MDx Health Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Biomarker Market Share by Type: 2020 VS 2027 Figure 2. Urine Features Figure 3. Blood Features Figure 4. Serum Features Figure 5. Global Prostate Cancer Biomarker Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Cancer Institutes Case Studies Figure 9. Prostate Cancer Biomarker Report Years Considered Figure 10. Global Prostate Cancer Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Prostate Cancer Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Prostate Cancer Biomarker Market Share by Regions: 2020 VS 2027 Figure 13. Global Prostate Cancer Biomarker Market Share by Regions (2022-2027) Figure 14. Global Prostate Cancer Biomarker Market Share by Players in 2020 Figure 15. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2020 Figure 17. Global Prostate Cancer Biomarker Revenue Market Share by Type (2016-2021) Figure 18. Global Prostate Cancer Biomarker Revenue Market Share by Type (2022-2027) Figure 19. North America Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Prostate Cancer Biomarker Market Share by Type (2016-2027) Figure 21. North America Prostate Cancer Biomarker Market Share by Application (2016-2027) Figure 22. North America Prostate Cancer Biomarker Market Share by Country (2016-2027) Figure 23. United States Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Prostate Cancer Biomarker Market Share by Type (2016-2027) Figure 27. Europe Prostate Cancer Biomarker Market Share by Application (2016-2027) Figure 28. Europe Prostate Cancer Biomarker Market Share by Country (2016-2027) Figure 29. Germany Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Prostate Cancer Biomarker Market Share by Type (2016-2027) Figure 37. Asia-Pacific Prostate Cancer Biomarker Market Share by Application (2016-2027) Figure 38. Asia-Pacific Prostate Cancer Biomarker Market Share by Region (2016-2027) Figure 39. China Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Prostate Cancer Biomarker Market Share by Type (2016-2027) Figure 47. Latin America Prostate Cancer Biomarker Market Share by Application (2016-2027) Figure 48. Latin America Prostate Cancer Biomarker Market Share by Country (2016-2027) Figure 49. Mexico Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Prostate Cancer Biomarker Market Share by Type (2016-2027) Figure 53. Middle East & Africa Prostate Cancer Biomarker Market Share by Application (2016-2027) Figure 54. Middle East & Africa Prostate Cancer Biomarker Market Share by Country (2016-2027) Figure 55. Turkey Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 59. QIAGEN Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 60. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 61. Beckman Coulter Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 62. Myriad Genetics Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 63. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 65. MDx Health Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Thermo Fisher Scientific QIAGEN Roche Diagnostics Beckman Coulter Myriad Genetics Sanofi-Aventis Pfizer MDx Health